Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
This study has been completed.
Study NCT00051662   Information provided by XOMA (US) LLC
First Received: January 14, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriatic Arthritis
Additional conditions recognized in this trial
Arthritis
Arthritis, Psoriatic
More general conditions related to this trial
Bone Diseases
Joint Diseases
Musculoskeletal Diseases
Psoriasis
Skin Diseases
Skin Diseases, Papulosquamous
Spinal Diseases
Spondylarthritis
Spondylarthropathies
Interventions listed in this trial
efalizumab
Sponsors listed in this trial
XOMA (US) LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services